MARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 25 Genetic Test
Welcome to DNA Labs UAE, where we offer the MARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 25 Genetic Test. This diagnostic test is designed to identify variations or mutations in the MARS2 gene, which is responsible for producing the enzyme methionyl-tRNA synthetase 2. This enzyme plays a crucial role in the process of oxidative phosphorylation, which is essential for cellular energy production.
Test Details
The MARS2 gene combined oxidative phosphorylation deficiency type 25 NGS genetic test utilizes next-generation sequencing (NGS) technology to analyze the DNA sequence of the MARS2 gene. By detecting any variations or mutations, this test can aid in the diagnosis of combined oxidative phosphorylation deficiency type 25.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the MARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 25 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by Combined Oxidative Phosphorylation Deficiency Type 25.
Symptoms and Diagnosis
Individuals who exhibit symptoms of mitochondrial disease, such as muscle weakness, exercise intolerance, developmental delays, and neurological problems, may be recommended to undergo the MARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 25 Genetic Test. This test can also be used for carrier testing in individuals with a family history of Combined Oxidative Phosphorylation Deficiency Type 25.
Interpretation and Importance
It is crucial to note that the MARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 25 Genetic Test is a diagnostic tool that should be interpreted by a healthcare professional or genetic counselor. The results of this test can guide treatment decisions, provide valuable information about the condition’s inheritance pattern, and assess the risk of recurrence.
At DNA Labs UAE, we are dedicated to providing accurate and reliable genetic testing services. If you have any questions or would like to schedule a test, please contact us.
Test Name | MARS2 Gene Combined oxidative phosphorylation deficiency type 25 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MARS2 Gene Combined oxidative phosphorylation deficiency type 25 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 25 |
Test Details |
MARS2 gene combined oxidative phosphorylation deficiency type 25 NGS genetic test is a diagnostic test that looks for variations or mutations in the MARS2 gene. This gene is responsible for providing instructions to produce an enzyme called methionyl-tRNA synthetase 2, which is involved in the process of oxidative phosphorylation. Oxidative phosphorylation is a crucial process in the production of cellular energy in the form of adenosine triphosphate (ATP). Mutations in the MARS2 gene can lead to a deficiency in oxidative phosphorylation, resulting in a condition known as combined oxidative phosphorylation deficiency type 25. This genetic test uses next-generation sequencing (NGS) technology to analyze the DNA sequence of the MARS2 gene and identify any variations or mutations. By detecting these genetic changes, the test can help in the diagnosis of combined oxidative phosphorylation deficiency type 25. The test may be recommended for individuals who exhibit symptoms of mitochondrial disease, such as muscle weakness, exercise intolerance, developmental delays, and neurological problems. It can also be used for carrier testing in individuals with a family history of combined oxidative phosphorylation deficiency type 25. It is important to note that this genetic test is a diagnostic tool and should be interpreted by a healthcare professional or genetic counselor. The results of the test can help guide treatment decisions and provide valuable information about the condition’s inheritance pattern and recurrence risk. |